Search filters

List of works by Jan Beyer-Westendorf

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients.

scientific article published on 24 October 2016

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial

scientific article published on 08 November 2019

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

scholarly article published 27 November 2018

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

scientific article published on 30 August 2016

Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation

scientific article published on 01 July 2020

Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)

scientific article published on 02 September 2020

Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119)

scientific article published on 25 April 2020

Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry

scientific article

Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism

scientific article published on 16 October 2014

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

scientific article published on 10 July 2018

Betrixaban for prevention of venous thromboembolism in acute medically ill patients.

scientific article published on 9 May 2018

Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs).

scientific article published on August 2015

Bleeding complications during anticoagulant treatment in patients with cancer

scientific article

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

scientific article published on 13 August 2019

COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

Cancer in males and risk of venous thromboembolism

scientific article published on April 2010

Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials

scientific article published on 21 November 2016

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

scientific article published on 30 July 2018

Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.

scientific article

Clinical history of cancer-associated splanchnic vein thrombosis

scientific article published on 11 December 2020

Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes

scientific article published on 10 June 2015

Comparative Risk of Major Bleeding with Rivaroxaban and Warfarin: Population Based Cohort Study of Unprovoked Venous Thromboembolism

scientific article published on 20 November 2018

Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis

scientific article published in December 2017

DOACS in women: pros and cons

scientific article published on 01 September 2019

Definition of major bleeding: Prognostic classification

scientific article published on 07 August 2020

Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE

scientific article published on 07 February 2019

Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preference

scientific article published on 19 February 2015

Diagnosis and Treatment of Pulmonary Embolism in Challenging Populations

scientific article published on 29 May 2018

Direct Oral Anticoagulants and Women

scientific article

Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry

scientific article

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

scientific article published in January 2020

Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.

scientific article

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism

scientific article published on 8 March 2018

Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis

scientific article published on 01 May 2018

Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry

scientific article published on 22 June 2017

Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

scientific article published on 05 March 2015

Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state

scientific article

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes

scientific article published on 11 June 2019

Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

scientific article published on 21 January 2016

Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data

scientific article published on 29 April 2020

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data

scientific article published on 25 June 2020

Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism

scientific article published on 01 October 2018

Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study

scientific article published on 30 May 2018

Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry

scientific article published on 29 November 2012

Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery ⬇️

scientific article published on March 23, 2012

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery – findings from the ORTHO‐TEP registry ⬇️

scientific article published on December 1, 2012

Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)

scientific article published on 01 December 2015

Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' reply.

scientific article

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients

scientific article published on 27 December 2019

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill

scholarly article by Benjamin Brenner et al published 15 April 2019 in Thrombosis journal

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study

scientific article published on 07 March 2019

Fibrinolysis for patients with intermediate-risk pulmonary embolism

scientific article published in April 2014

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study

scientific article

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

scientific article published on 07 February 2019

Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry

scientific article published on 10 May 2017

Guidance for the management of venous thrombosis in unusual sites

scientific article

Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population

scientific article published on 07 September 2018

Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.

scientific article published on 24 March 2016

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE

scientific article published on 21 December 2018

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

scientific article published on March 2017

In Reply

scientific article published on 01 June 2019

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

scientific article published on 18 December 2018

Increase of gastrointestinal bleeding with new oral anticoagulants: problems of a meta-analysis

scientific article published on 24 September 2013

Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed: Author reply

scientific article published on 30 December 2015

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

scientific article published on 25 April 2019

Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboembo

scientific article published on 26 October 2016

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis

scholarly article by Marco Senzolo et al published 15 August 2018 in Clinical and translational gastroenterology

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

scientific article

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.

scientific article published on 13 July 2015

Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease

scientific article published on 27 January 2019

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses

scientific article published on 3 June 2016

Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life

scientific article published on 9 November 2016

Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs

scientific article published on 16 February 2017

Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series

scientific article published on October 2016

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding

scientific article published on 13 February 2019

Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy

scientific article published on 16 January 2020

Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

article published in 2019

Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation.

scientific article published on 11 August 2017

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.

scientific article published on 28 September 2014

Outpatient or inpatient treatment for acute pulmonary embolism: a retrospective cohort study of 439 consecutive patients

scientific article

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

scientific article

Pharmacokinetics of rivaroxaban after bariatric surgery: a case report

scientific article published in November 2013

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis

scientific article published on 01 September 2016

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.

scientific article published in January 2018

Predictors of deep venous thrombosis in patients admitted to rehabilitation clinics after major orthopaedic surgery

scientific article published in January 2013

Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting

scientific article published on 07 July 2016

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial

scientific article published on 16 February 2017

Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism

scientific article

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRY

scientific article published on 19 April 2020

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

scientific article

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation

scientific article published on 31 January 2016

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

scientific article published on 22 December 2015

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

scientific article published on 01 August 2019

Response to the Letter by Lucijanic et al., regarding our manuscript "Management and outcome of gastro-intestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs"

scientific article published on 28 June 2017

Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study

scientific article published on 07 September 2018

Risk of recurrent venous thromboembolism according to baseline risk factor profiles

scientific article published on 01 April 2018

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis

scientific article published on 01 January 2020

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

scientific article published on 05 November 2019

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation

scientific article published on 04 April 2020

Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice

scientific article published on 31 January 2017

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

scientific article published on 18 March 2017

Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice

scientific article published on 14 September 2016

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

scientific article

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study

scientific article published in April 2014

Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry

scientific article

Safety of venous ultrasound in suspected DVT--still a matter of concern?

scientific article published on 01 July 2009

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.

scientific article published on 21 May 2015

Severe Hemorrhage Associated With Oral Anticoagulants

scientific article published on 01 May 2020

Sex hormones and venous thromboembolism – from contraception to hormone replacement therapy

scientific article published on 16 July 2018

Small clots with large impact

scientific article published on August 2015

Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol

scientific article

Successful treatment of acute portal vein thrombosis with rivaroxaban

scientific article published on 11 July 2013

Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial

scientific article published on 01 August 2016

Survival and Quality of Life after Early Discharge in Low-Risk Pulmonary Embolism

scientific article published on 28 August 2020

Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease

scientific article published on 08 July 2020

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

scientific article published in February 2018

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients

scientific article published on 15 August 2018

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study

scientific article published on 22 May 2019

Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management

scientific article published on 20 October 2020

Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies

scientific article published on 18 August 2016

Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy‐resistant venous thrombosis treated with dabigatran and fondaparinux ⬇️

scientific article published on October 1, 2011

Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study

scientific article published on 21 May 2015

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

scientific article published on 12 April 2018

Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia

scientific article published in November 2017

Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy

scientific article published on 25 February 2016

Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry

scientific article published on 01 April 2018

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

scientific article

[Bleeding complications under oral anticoagulation]

scientific article published on 6 February 2015

[New oral anticoagulants and endoscopy--what do you have to consider?]

scientific article published on 11 August 2015

[Thromboembolic Complications in COVID-19]

scientific article published on 30 November 2020

Paulina is supported by:

About Paulina

Help